-
2022-502778-18-00
5
2023-11-17
ulcerative colitis
-
2022-502476-23-00
4
2023-10-25
Treatment of immunotherapy-naive patients with previously untreated or
-
2023-504418-30-00
4
2023-10-24
Idiopathic Pulmonary Fibrosis
-
2024-511007-41-00
9
2023-10-03
Untreated advanced or metastatic non-squamous non-small cell lung canc
-
2022-502057-33-00
7
2023-10-02
Relapsed/refractory multiple myeloma
-
2023-509833-38-00
5
2023-09-20
Birch Pollen-induced Allergic Rhinoconjunctivitis
-
2022-502174-16-00
5
2023-09-13
Macular edema secondary to retinal vein occlusion
-
2022-502393-16-00
5
2023-09-06
Moderately to Severely Active Ulcerative Colitis
-
2022-502249-90-00
4
2023-08-31
Plaque Psoriasis
-
2022-502267-37-00
9
2023-07-17
metastatic colorectal cancer
-
2022-500536-11-01
5
2023-06-08
Moderately to severely active ulcerative colitis
-
2023-506268-15-00
5
2023-06-05
Chronic Rhinosinusitis (CRS) in Adults
-
2024-512558-40-00
4
2023-05-11
Mild-to-moderate ulcerative colitis
-
2024-517612-29-00
11
2023-02-14
acute heart failure
-
2024-512258-91-00
5
2023-02-03
Generalized Myasthenia Gravis (gMG)
-
2024-515185-13-00
5
2022-12-21
geographic atrophy
-
2023-503794-38-00
5
2022-11-24
Prevention of stroke or systemic embolism in atrial fibrillation
-
2023-505904-41-00
5
2022-11-17
Hereditary Angioedema Type I or II
-
2024-512803-37-00
5
2022-10-05
Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
-
2023-507208-30-00
10
2022-09-20
Diabetic Macular Edema (DME)
-
2024-513992-42-00
10
2022-09-13
venous thromboembolism (VTE) in patients with gastrointestinal/genitou
-
2023-509569-19-00
10
2022-08-10
venous thromboembolism (VTE)
-
2024-516743-34-00
3
2022-07-25
IgAN is Primary Immunoglobulin A Nephropathy (IgAN) (also known as
Ber
-
2023-508645-40-00
10
2022-05-10
Bullous Pemphigoid (BP)